MedPath

Study to Assess the Incidence of Intussusception in Children < 2 Years of Age in Singapore

Completed
Conditions
Intussusception
Interventions
Other: Screening sheets
Registration Number
NCT01177839
Lead Sponsor
GlaxoSmithKline
Brief Summary

This prospective study aims to estimate the incidence of intussusception among children \< 2 years old through hospital-based surveillance in Singapore.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
178
Inclusion Criteria
  • A male or female infant aged < 24months at the time of diagnosis of intussusception.
  • Subject is diagnosed with definite, probable, possible, suspected intussusception during the period of at least one year beginning at study start.
  • Written informed consent obtained from the parent or guardian of the subject.
Exclusion Criteria
  • A male or female infant ≥ 24 months of age at the time of intussusception diagnosis.
  • The subject has had a radiographically or surgically confirmed case of intussusception prior to the current episode.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Intussusception cohortScreening sheetsSubjects with Intussusception
Primary Outcome Measures
NameTimeMethod
Occurrence of definite, probable and possible IS cases in children < 5 yrs of ageAverage timeframe: one year
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

GSK Investigational Site

🇸🇬

Singapore, Singapore

© Copyright 2025. All Rights Reserved by MedPath